Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity-Reference-Cited by-同舟云学术

Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity

Published:2020-06-25 Issue:3 Volume:374 Page:392-403
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Raleigh Michael D.,Accetturo Claudia,Pravetoni Marco^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference54 articles.

1. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents

2. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection;Azizi;Exp Parasitol,2018

3. Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in rats;Bartus;Neuropsychopharmacology,2003

4. Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose–effects and time-course

5. Antagonists in the medical management of opioid use disorders: historical and existing treatment strategies;Bisaga;Am J Addict,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines;Biomaterials;2025-02

2. A two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanyl;2024-08-29

3. Opioid vaccine clinical testing: lessons learned;Current Opinion in Psychiatry;2024-05-01

4. A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood;Vaccine;2024-01

5. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans;Expert Opinion on Drug Metabolism & Toxicology;2023-10-03